Biapenem

DRUG2 trials

Sponsors

Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company), Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions

Bacterial InfectionsHealthy VolunteersHigh-dose Biapenem

Phase 1

Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination

CompletedNCT01772836

Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)Bacterial Infections, Healthy Volunteers

Start: 2013-03-31End: 2013-03-31Target: 30Updated: 2013-07-11

Unknown Phase

Clinical Efficacy of Combination Therapy Based on High-dose Biapenem in CRKP Infections

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityHigh-dose Biapenem

Start: 2019-06-01End: 2021-08-01Target: 200Updated: 2020-09-17